Future Perspectives on PAT & QbD Utilisation

Sune Klint Andersen
Contributor: Sune Klint Andersen
Posted: 01/29/2015

In this interview Sune Klint Andersen,Principal Scientist in Drying Processes and Particle Technology in CMC at Novo Nordisk A/S, Denmark, shares his future perspectives on process analytical technology (PAT) & quality by design (QbD) utilisation. Klint Andersen also discusses what impact QbD has on process understanding, product development and product quality and the main challenges encountered when adopting QbD.

Pharma IQ:
What is meant by Quality by Design and what are the key business benefits of QbD?

Sune Klint Andersen
Contributor: Sune Klint Andersen
Posted: 01/29/2015